Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hearing loss
Biotech
Regeneron shares updated data on hearing loss gene therapy
Regeneron posted updated clinical data on DB-OTO, providing more evidence of the gene therapy’s potential to treat a rare genetic form of deafness.
Nick Paul Taylor
Oct 12, 2025 10:18am
Lineage tunes up hearing loss transplant with $12M research pact
Aug 26, 2025 11:00am
Lilly strengthens RNA pipeline with $1.3B hearing loss pact
May 16, 2025 7:34am
Regeneron gene therapy restores hearing in 10 of 11 children
Feb 24, 2025 3:00pm
Pepper chemical prevents hearing loss from powerful antibiotics
Aug 8, 2024 10:40am
Regeneron's 'protein factory' gene therapy restores hearing
May 8, 2024 6:00am